Use of T cell-based diagnosis of tuberculosis infection to optimize interpretation of tuberculin skin testing for child tuberculosis contacts

Clinical Infectious Diseases

Volumn 48, Issue 3, 2009, Pages 302-312

  Bakir, Mustafa ^a   Dosanjh, Davinder P S ^c   Deeks, Jonathan J ^d   Soysal, Ahmet ^a   Millington, Kerry A ^c,e   Efe, Serpil ^a   Aslan, Yasemin ^a   Polat, Dilek ^b   Kodalli, Nihat ^a   Yagci, Aysegul ^a   Barlan, Isil ^a   Bahceciler, Nerin ^a   Demiralp, Emel E ^a   Lalvani, Ajit ^c,e  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b Turkish Ministry of Health   (Turkey)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^e NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

ARTICLE; CHILD; CONTROLLED STUDY; DIAGNOSTIC ERROR; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; T LYMPHOCYTE; TUBERCULIN TEST; TUBERCULOSIS; TURKEY (REPUBLIC);

ADOLESCENT; BCG VACCINE; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; SENSITIVITY AND SPECIFICITY; T-LYMPHOCYTES; TUBERCULIN TEST; TUBERCULOSIS; TURKEY;

EID: 58749105799     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/595847     Document Type: Article

References (56)

1. Gedde-Dahl T. Tuberculous infection in the light of tuberculin matriculation. Am J Hyg 1952; 56:139-214.
2. Marais BJ, Gie RP, Schaaf HS, Beyers N, Donald PR, Starke JR. Childhood pulmonary tuberculosis: old wisdom and new challenges. Am J Respir Crit Care Med 2006; 173:1078-90.
3. Hsu KH. Thirty years after isoniazid: its impact on tuberculosis in children and adolescents. JAMA 1984; 251:1283-5.
4. Wang L, Turner MO, Elwood RK, Schulzer M, FitzGerald JM. A meta-analysis of the effect of bacille Calmette Guérin vaccination on tuberculin skin test measurements. Thorax 2002; 57:804-9.
5. National Collaborating Centre for Chronic Conditions. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. London: Royal College of Physicians, 2006.
6. American Thoracic Society. Diagnostic standards and classification of tuberculosis in adults and children. Am J Respir Crit Care Med 2000; 161:1376-95.
7. Fundação Nacional de Saúde. Tuberculose - guia de vigilancia epidemiologica. Brasília, Brazil: Ministério da Saúde, 2002:1-99.
8. South African Department of Health. The South African tuberculosis control programme - practical guidelines. Cape Town, South Africa: Department of Health, 2000.
9. World Health Organization. Treatment of tuberculosis: guidelines for national programmes. Geneva: World Health Organization, 2003.
10. Türkiye Cumhuriyeti Saglik Bakanligi Verem Savaşi Daire Başkanligi. Türkiye'de tüberkülozun kontrolü için başvuru kitabi. Ankara, Turkey: 2003. Available at: http://www.istanbulsaglik.gov.tr/w/sb/bh/belge/tuberkitabi.pdf. Accessed 20 December 2008.
11. Chauhan LS, Arora VK. Management of pediatric tuberculosis under the revised national tuberculosis control programme. Indian J Pediatr 2004; 71:341-3.
12. Richeldi L. An update on the diagnosis of tuberculosis infection. Am J Respir Crit Care Med 2006; 174:736-42.
13. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007; 146:340-54.
14. Lalvani A. Diagnosing tuberculosis infection in the 21st century: new tools to tackle an old enemy. Chest 2007; 131:1898-906.
15. Pai M, Riley LW, Colford JM Jr. Interferon-γ assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 2004;4:761-76.
16. Lalvani A, Pathan AA, Durkan H, et al. Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet 2001; 357:2017-21.
17. Richeldi L, Ewer K, Losi M, et al. T cell-based tracking of multidrug resistant tuberculosis infection after brief exposure. Am J Respir Crit Care Med 2004; 170:288-95.
18. Shams H, Weis SE, Klucar P, et al. Enzyme-linked immunospot and tuberculin skin testing to detect latent tuberculosis infection. Am J Respir Crit Care Med 2005; 172:1161-8.
19. Lalvani A, Pathan AA, McShane H, et al. Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Am J Respir Crit Care Med 2001; 163:824-8.
20. Pathan AA, Wilkinson KA, Klenerman P, et al. Direct ex vivo analysis of antigen-specific IFN-γ-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment. J Immunol 2001; 167:5217-25.
21. Meier T, Eulenbruch HP, Wrighton-Smith P, Enders G, Regnath T. Sensitivity of a new commercial enzyme-linked immunospot assay (T SPOT-TB) for diagnosis of tuberculosis in clinical practice. Eur J Clin Microbiol Infect Dis 2005; 24:529-36.
22. Chapman AL, Munkanta M, Wilkinson KA, et al. Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells. AIDS 2002; 16:2285-93.
23. Zellweger JP, Zellweger A, Ansermet S, de Senarclens B, Wrighton-Smith P. Contact tracing using a new T-cell-based test: better correlation with tuberculosis exposure than the tuberculin skin test. Int J Tuberc Lung Dis 2005; 9:1242-7.
24. Arend SM, Thijsen SF, Leyten EM, et al. Comparison of two interferon-γ assays and tuberculin skin test for tracing tuberculosis contacts. Am J Respir Crit Care Med 2007; 175:618-27.
25. Ferrara G, Losi M, D'Amico R, et al. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet 2006; 367:1328-34.
26. Porsa E, Cheng L, Graviss EA. Comparison of an ESAT-6/CFP-10 peptide-based enzyme-linked immunospot assay to a tuberculin skin test for screening of a population at moderate risk of contracting tuberculosis. Clin Vaccine Immunol 2007; 14:714-9.
27. Kang YA, Lee HW, Hwang SS, et al. Usefulness of whole-blood interferon-γ assay and interferon-γ enzyme-linked immunospot assay in the diagnosis of active pulmonary tuberculosis. Chest 2007; 132:959-65.
28. Lee JY, Choi HJ, Park IN, et al. Comparison of two commercial interferon-γ assays for diagnosing Mycobacterium tuberculosis infection. Eur Respir J 2006; 28:24-30.
29. Liebeschuetz S, Bamber S, Ewer K, Deeks J, Pathan AA, Lalvani A. Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study. Lancet 2004; 364:2196-203.
30. Soysal A, Millington KA, Bakir M, et al. Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study. Lancet 2005; 366:1443-51.
31. Detjen AK, Keil T, Roll S, et al. Interferon-γ release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis. Clin Infect Dis 2007; 45:322-8.
32. Ewer K, Deeks J, Alvarez L, et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 2003; 361:1168-73.
33. Richeldi L, Ewer K, Losi M, et al. T-cell-based diagnosis of neonatal multidrug-resistant latent tuberculosis infection. Pediatrics 2007; 119:e1-5.
34. Lalvani A, Millington KA. T cell-based diagnosis of childhood tuberculosis infection. Curr Opin Infect Dis 2007; 20:264-71.
35. World Health Organization. Global TB database. Available at: http://www.who.int/tb/country/global-tb-database/en/index.html. Accessed 20 December 2008.
36. Turkish Ministry of Health. Reported cases and carriers of AIDS distribution by age and gender. 2005. Available at: http://www.saglik. gov.tr/extras/istatistikler/2005geribildirim/Tablo%2021.htm. Accessed 22 December 2008.
37. World Health Organization. Immunization profile - the Republic of Turkey. Available at: http://www.who.int/immunization-monitoring/en/globalsummary/ countryprofileselect.cfm. Accessed 20 December 2008.
38. Lalvani A, Nagvenkar P, Udwadia Z, et al. Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians. J Infect Dis 2001; 183:469-77.
39. Dosanjh DP, Hinks TS, Innes JA, et al. Improved diagnostic evaluation of suspected tuberculosis. Ann Intern Med 2008; 148:325-36.
40. Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008; 149:177-84.
41. Dorfman DD, Alf E. Maximum liklihood estimation of parameters of signal detection theory - a direct solution. Psychometrika 1968; 33:117-24.
42. Berkel GM, Cobelens FGJ, de Vries G, Draayer-Jansen IWE, Borgdorff MW. Tuberculin skin test: estimation of positive and negative predictive values from routine data. Int J Tuberc Lung Dis 2005; 9:310-6.
43. Edwards LB, Acquaviva FA, Livesay VT, Cross FW, Palmer CE. An atlas of sensitivity to tuberculin, PPD-B, and histoplasmin in the United States. Am Rev Respir Dis 1969; 99(Suppl):1-132.
44. Lewinsohn DA, Gennaro ML, Scholvinck L, Lewinsohn DM. Tuberculosis immunology in children: diagnostic and therapeutic challenges and opportunities. Int J Tuberc Lung Dis 2004; 8:658-74.
45. Comstock GW, Livesay VT, Woolpert SF. The prognosis of a positive tuberculin reaction in childhood and adolescence. Am J Epidemiol 1974; 99:131-8.
46. Starke JR. Childhood tuberculosis during the 1990s. Pediatr Rev 1992; 13:343-53.
47. Murray DL, Brewer TF. Multiple bacille Calmette-Guérin vaccinations and interpretation of the Mantoux test in children. Clin Infect Dis 1995; 21:1533-4.
48. Shaw LW. Field studies on immunization against tuberculosis. I. Tuberculin allergy following BCG vaccination of school children in Muscogee County, Georgia. Public Health Rep 1951; 66:1415-6.
49. Marcus JH, Khassis Y. The tuberculin sensitivity in BCG vaccinated infants and children in Israel. Acta Tuberc Pneumol Scand 1965; 46:113-22.
50. Black GF, Weir RE, Floyd S, et al. BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies. Lancet 2002; 359:1393-401.
51. Dye C, Bassili A, Bierrenbach AL, et al. Measuring tuberculosis burden, trends, and the impact of control programmes. Lancet Infect Dis 2008; 8:233-43.
52. Hill PC, Brookes RH, Fox A, et al. Large-scale evaluation of enzyme-linked immunospot assay and skin test for diagnosis of Mycobacterium tuberculosis infection against a gradient of exposure in The Gambia. Clin Infect Dis 2004; 38:966-73.
53. Hill PC, Brookes RH, Adetifa IM, et al. Comparison of enzyme-linked immunospot assay and tuberculin skin test in healthy children exposed to Mycobacterium tuberculosis. Pediatrics 2006; 117:1542-8.
54. Lalvani A. Prognostic value of a T-cell-based, interferon-γ biomarker in Turkish children - authors' response. Ann Intern Med 2008; published online 7 November. Available at: http://www.annals.org/cgi/eletters/ 149/11/777. Accessed 22 December 2008.
55. Bakir M, Millington KA, Soysal A, et al. Prognostic value of a T-cell-based, interferon-γ biomarker in children with tuberculosis contact. Ann Intern Med 2008; 149:777.
56. Rodrigues LC, Pereira SM, Cunha SS, et al. Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trial. Lancet 2005; 366:1290-5.